A Practical Approach to the Management of Chronic Non-Cancer Nociceptive Pain in the Elderly

American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57(8):1331–46.

Fine PG . Chronic pain management in older adults: special considerations. J Pain Symptom Manage 2009;38(2 Suppl):S4–14.

Reisner L . Pharmacological management of persistent pain in older persons. J Pain 2011;12(3 Suppl 1):S21–29.

Ramage-Morin PL . Chronic pain in Canadian seniors. Statistics Canada Health Reports, Vol. 19, No. 1, February 2008. Available: www.statcan.gc.ca/pub/82-003-x/2008001/article/10514-eng.pdf (accessed April 9, 2011).

Bruckenthal P Reid MC Reisner L . Special issues in the management of chronic pain in older adults. Pain Med 2009;10(Suppl 2):S67–78.

Jones RM Rospond RM . Patient assessment in pharmacy practice. 1st ed. Baltimore (MD): Lippincott Williams & Wilkins; 2003.

Maxwell CJ Dalby DM Slater M . The prevalence and management of current daily pain among older home care clients. Pain 2008;138(1):208–16.

Jovey RD . Pain pathways and pathophysiology. In: Jovey D editor. Managing pain. The Canadian healthcare professionals' reference. 2nd ed. Toronto (ON): Health Care & Final Publishing; 2002.

Bruckenthal P . Assessment of pain in the elderly adult. Clin Geriatr Med 2008;24(2):213–26.

Murdaugh LB . Competence assessment tools for health-system pharmacies. 4th ed. Bethesda (MD): American Society of Health-System Pharmacists; 2008.

Cooper JW Burfield AH . Medication interventions for fall prevention in the older adults. J Am Pharm Assoc 2009;49(3):e70–82.

National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. Part B: recommendations for practice. April 30, 2010. Available: http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_b_v5_6.pdf (accessed April 2, 2011).

Strassels SA McNicol E Suleman R . Pharmacotherapy of pain in older adults. Clin Geriatr Med 2008;24(2):275–98.

Mangoni AA Jackson SHD . Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004;57(1):6–14.

Gloth MF III . Pharmacological management of persistent pain in older persons: focus on opioids and nonopioids. J Pain 2011;12(3 Suppl 1):S14–20.

Watkins PB Kaplowitz N Slattery JT . Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006;296(1):87–93.

Dart RC Baileu E . Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy 2007;27(9):1219–30.

McNeil Consumer Healthcare. Tylenol professional product information. 2010. Available: www.tylenolprofessional.com/assets/TYL_PPI.pdf (accessed April 24, 2011).

Medscape Reference. Drugs, Diseases & Procedures. Drug-induced hepatotoxicity. April 26, 2010. Available: http://emedi-cine.medscape.com/article/169814-overview (accessed August 12, 2011).

Parra D Beckey NP Stevens GR . The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy 2007;27(5):675–83.

Zhang Q Bal-dit-Sollier C Drouet L . Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial. Eur J Clin Pharmacol 2011;67(3):309–14.

Antman EM Bennett JS Daugherty A . Use of nonsteroidal anti-inflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115(2):1634–42.

Bavry AA Khaliq A Gong Y . Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. Am J Med 2011;124(7):614–20.

Ejaz P Bhojani K Joshi CR . NSAIDs and kidney. J Assoc Physicians India 2004;52:632–40.

Silverstein FE Faich G Goldstein JL . Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. CLASS study. JAMA 2002;284:1247–55.

Singh G Fort JG Goldstein JL . Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study. Am J Med 2006;119:255–66.

Schnitzer TJ Burmester GR Mysler E . Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004;364:665–74.

MacDonald TM Wei L . Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003:361(9357)573–4.

Kruth K Glynn R Walker A . Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal anti-inflammatory drugs. Circulation 2003;108(10):1191–5.

Kimmel SE Berlin JA Reilly M . The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin. J Am Coll Cardiol 2004;43(6):985–90.

Curtis JP Krumholz HM . The case for an adverse interaction between aspirin and non-steroidal anti-inflammatory drugs: is it time to believe the hype? J Am Coll Cardiol 2004;43(6):991–3.

US Food and Drug Administration. Information for healthcare professionals: concomitant use of ibuprofen and aspirin. September 2006. Available: www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetylnformationforPatientsandProviders/ucm125222.htm (accessed August 14, 2011).

Janssen Inc. Product Monograph: Tramacet. July 14, 2005. Available: www.janssen-ortho.com/joi/pdf_files/tramacet_e.pdf (accessed August 14, 2011).

Rosenberg MT . The role of tramadol ER in the treatment of chronic pain. Int J Clin Pract 2009;63(10):1531–43.

Janssen Inc. Product Monograph: Ultram. Janssen-Ortho Inc. October 7, 2010. Available: www.janssen.ca/JOI/pdf_files/ultram_E.pdf (accessed August 14, 2011).

Inturrisi CE . Clinical pharmacology of opioids of pain. Clin J Pain 2002;18(4 Suppl):S3–13.

Trescot AM Datta S Lee M . Opioid pharmacology. Pain Physician 2008;11(2 Suppl):S133–53.

Jovey RD . Opioid analgesics. In: Jovey D editor. Managing pain. The Canadian healthcare professionals' reference. 2nd ed. Toronto (ON): Health Care & Final Publishing; 2002.

Cupp M . Analgesic options for patients with allergic-type opioid reactions. Pharmacist's Letter/Prescriber's Letter 2006;22(2):220201.

Pergolizzi J Boger RH Budd K . Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008;8(4):287–313.

Smith H Burckenthal P . Implications of opioid analgesia for medically complicated patients. Drugs Aging 2010;27(5)417–33.

Hanlon JT Aspinall L Semla TP . Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. J Am Geriatr Soc 2009;57(2):335–40.

Harris JD . Management of expected and unexpected opioid-related side effects. Clin J Pain 2008;24(Suppl 10):S8–13.

Solomon DH Rassen HA Glynn RJ . The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;170(22):1968–76.

Silverman SM . Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician 2009;12(3):679–84.

Vadivelu N Hines RL . Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin Interv Aging 2008;3(3):421–30.

Purdue Pharma. Product monograph: Butrans Buprenorphine Trandermal System 5, 10 and 20 mcg/h. July 10, 2010. Available: www.purdue.ca/files/BuTrans%20PM%20EN.pdf (accessed August 14, 2011).